Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Materials

Molecular Logic Gates Meet Cancer Therapy

Scientists design a molecule that must perform a logic computation before it can go about killing cancer cells via photodynamic therapy

by Sarah Everts
January 19, 2009 | A version of this story appeared in Volume 87, Issue 3

Researchers in Turkey are reporting a first attempt to marry molecular computing with photodynamic cancer therapy (J. Am. Chem. Soc. 2009, 131, 48). The idea is to design a molecule that must perform a logic computation before it can help kill cancer cells. In this case, the logic function for the sensitizer molecule (shown) has to recognize two characteristics inherent to cancer cells: high concentrations of H+ and Na+. When the conditions are satisfied, which in computing terminology is referred to as “AND” logic, the molecule, in the presence of light, generates singlet oxygen (diamagnetic O2), a reactive oxygen species that destroys cells. The proof-of-principle work was undertaken by Suriye Ozlem of Middle East Technical University and Engin U. Akkaya of Bilkent University, both in Ankara. “As the field of molecular computing grows, it needs applications in areas where conventional silicon computing cannot go—such as inside biological cells,” comments A. Prasanna de Silva, a chemist at Queen’s University of Belfast, in Northern Ireland. The work adds to the growing evidence that “this goal is attainable,” de Silva says, although getting the new molecule across cell membranes may require adding water-soluble groups.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.